Cargando…

ODP580 A Case of New Onset Primary Adrenal Insufficiency in COVID Infection

BACKGROUND: Accumulating body of evidence shows that SARS-CoV-2 infection in COVID-19 is linked to a variety of autoimmune complications including autoimmune endocrinopathies. Here we report a case of newly diagnosed Addison's disease post-COVID-19 infection. CASE DESCRIPTION: A 23-year-old mal...

Descripción completa

Detalles Bibliográficos
Autores principales: Beshay, Lauren, Yang, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625592/
http://dx.doi.org/10.1210/jendso/bvac150.153
_version_ 1784822537101770752
author Beshay, Lauren
Yang, Qin
Beshay, Lauren
author_facet Beshay, Lauren
Yang, Qin
Beshay, Lauren
author_sort Beshay, Lauren
collection PubMed
description BACKGROUND: Accumulating body of evidence shows that SARS-CoV-2 infection in COVID-19 is linked to a variety of autoimmune complications including autoimmune endocrinopathies. Here we report a case of newly diagnosed Addison's disease post-COVID-19 infection. CASE DESCRIPTION: A 23-year-old male with a history of three episodes of acute disseminated encephalomyelitis (ADEM) in childhood, was brought into the emergency department (ED) by EMS after being found down with a blood glucose of 28 at the field. Prior to presentation, he reported 3 days of sore throat, nausea, vomiting, fatigue, and chills. He takes no home medications, and is not vaccinated against COVID-19. In the ED, the physical exam is notable for temperature 39°C, pulse 145, BP 80/42, RR 39, and no mucocutaneous hyperpigmentation. Labs revealed a positive COVID test, serum sodium 125 mmol/L (135-145), potassium 3.1 mmol/L (3.5-4.1), and persistent hypoglycemia. TSH 1.89 μIU/mL (0.45-4.12). A morning baseline cortisol was 4 mcg/dl (ref: >18) with ACTH level of >1250 pg/ml (0-45). A high-dose 250 mcg ACTH stimulation test followed; with cortisol levels of 3, and 3 mcg/dl (ref: >18) at 30, and 60 minutes; respectively. Aldosterone <3. 0 ng/dl (4. 0-31. 0), and anti-21-hydroxylase antibody was positive (ref: negative). A CT scan of the abdomen with contrast demonstrated mildly atrophied bilateral adrenal glands. The hypotension and hyponatremia resolved after initiation of intravenous hydrocortisone, and he was discharged on hydrocortisone and fludrocortisone. CONCLUSION: The patient's symptoms, elevated ACTH, low cortisol, and presence of 21-hydroxylase antibodies, are consistent with autoimmune Addison's disease. Since ADEM is an autoimmune condition, it is likely that the patient had underlying undiagnosed Addison's disease and COVID-19 triggered an adrenal crisis. There is also a possibility that SARS-CoV-2 infection may have induced a higher titer of adrenal antibody, leading to the exacerbation of Addison's disease. The case highlights the importance of considering adrenal insufficiency as a diagnostic differential in hemodynamically unstable COVID-19 patients, especially those with underlying autoimmune conditions. Presentation: No date and time listed
format Online
Article
Text
id pubmed-9625592
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96255922022-11-14 ODP580 A Case of New Onset Primary Adrenal Insufficiency in COVID Infection Beshay, Lauren Yang, Qin Beshay, Lauren J Endocr Soc Adrenal BACKGROUND: Accumulating body of evidence shows that SARS-CoV-2 infection in COVID-19 is linked to a variety of autoimmune complications including autoimmune endocrinopathies. Here we report a case of newly diagnosed Addison's disease post-COVID-19 infection. CASE DESCRIPTION: A 23-year-old male with a history of three episodes of acute disseminated encephalomyelitis (ADEM) in childhood, was brought into the emergency department (ED) by EMS after being found down with a blood glucose of 28 at the field. Prior to presentation, he reported 3 days of sore throat, nausea, vomiting, fatigue, and chills. He takes no home medications, and is not vaccinated against COVID-19. In the ED, the physical exam is notable for temperature 39°C, pulse 145, BP 80/42, RR 39, and no mucocutaneous hyperpigmentation. Labs revealed a positive COVID test, serum sodium 125 mmol/L (135-145), potassium 3.1 mmol/L (3.5-4.1), and persistent hypoglycemia. TSH 1.89 μIU/mL (0.45-4.12). A morning baseline cortisol was 4 mcg/dl (ref: >18) with ACTH level of >1250 pg/ml (0-45). A high-dose 250 mcg ACTH stimulation test followed; with cortisol levels of 3, and 3 mcg/dl (ref: >18) at 30, and 60 minutes; respectively. Aldosterone <3. 0 ng/dl (4. 0-31. 0), and anti-21-hydroxylase antibody was positive (ref: negative). A CT scan of the abdomen with contrast demonstrated mildly atrophied bilateral adrenal glands. The hypotension and hyponatremia resolved after initiation of intravenous hydrocortisone, and he was discharged on hydrocortisone and fludrocortisone. CONCLUSION: The patient's symptoms, elevated ACTH, low cortisol, and presence of 21-hydroxylase antibodies, are consistent with autoimmune Addison's disease. Since ADEM is an autoimmune condition, it is likely that the patient had underlying undiagnosed Addison's disease and COVID-19 triggered an adrenal crisis. There is also a possibility that SARS-CoV-2 infection may have induced a higher titer of adrenal antibody, leading to the exacerbation of Addison's disease. The case highlights the importance of considering adrenal insufficiency as a diagnostic differential in hemodynamically unstable COVID-19 patients, especially those with underlying autoimmune conditions. Presentation: No date and time listed Oxford University Press 2022-11-01 /pmc/articles/PMC9625592/ http://dx.doi.org/10.1210/jendso/bvac150.153 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Adrenal
Beshay, Lauren
Yang, Qin
Beshay, Lauren
ODP580 A Case of New Onset Primary Adrenal Insufficiency in COVID Infection
title ODP580 A Case of New Onset Primary Adrenal Insufficiency in COVID Infection
title_full ODP580 A Case of New Onset Primary Adrenal Insufficiency in COVID Infection
title_fullStr ODP580 A Case of New Onset Primary Adrenal Insufficiency in COVID Infection
title_full_unstemmed ODP580 A Case of New Onset Primary Adrenal Insufficiency in COVID Infection
title_short ODP580 A Case of New Onset Primary Adrenal Insufficiency in COVID Infection
title_sort odp580 a case of new onset primary adrenal insufficiency in covid infection
topic Adrenal
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625592/
http://dx.doi.org/10.1210/jendso/bvac150.153
work_keys_str_mv AT beshaylauren odp580acaseofnewonsetprimaryadrenalinsufficiencyincovidinfection
AT yangqin odp580acaseofnewonsetprimaryadrenalinsufficiencyincovidinfection
AT beshaylauren odp580acaseofnewonsetprimaryadrenalinsufficiencyincovidinfection